ALG1001

• Description :

  ALG1001 (Risuteganib, ALG-1001) is a first-in-class, RGD class oligopeptide that inhibits integrin receptors (αvβ3, αvβ5, and α5β1) associated with angiogenesis.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  637.666

• Molecular Formula :

  C22H39N9O11S

• Notes :

  Research use only, not for human use.

• Receptor :

  Integrin

• CAS Number :

  1307293-62-4